Ashot's U.S. Expansion Hits Legal Snag Over Georgia Property Dispute
Ashot Industries faces legal hurdles in Georgia regarding land acquired for a new U.S. manufacturing plant, as existing tenant PSI challenges lease terms and debt repayment.
Ashot Ashkelon Industries, one of the most prominent stocks on the Tel Aviv Stock Exchange over the past three years, has targeted the United States as a key future growth engine. However, its initiative to establish local manufacturing operations in Georgia and a potential expedited licensing process has recently encountered a legal dispute surrounding the acquired property and the company already operating a plant there.
Ashot operates primarily through Reshef Technologies (77.6%), which develops and manufactures electronic fuzes. In 2025, Reshef established the American subsidiary Flash Fuzes USA with the aim of setting up a fuze manufacturing plant in the U.S. Last July, the American company, through designated entities under its control, completed the acquisition of 882 dunams in Georgia for $2 million. The site includes vacant land designated for the new plant alongside an industrial site where a pyrotechnic manufacturing facility for the defense market is already operational.
Legal Disputes in Georgia
The existing plant is operated by Pyrotechnic Specialties (PSI) under a lease agreement with the previous owner. Establishing U.S. manufacturing capabilities is part of Ashot's strategy to transform Reshef into an international company. Ashot CEO Haim Stoffler previously stated that the company is establishing plants in the U.S., Europe, and India, with the goal that the majority of Reshef's activity will eventually be outside of Israel.
However, a legal battle is currently underway regarding the Georgia site. PSI claims that an agreement signed in 2025 extended its right to lease the plant until June 2029, and is seeking an injunction to prevent any infringement on its use of the property while the validity of the lease is being litigated.
"The legal proceeding in the U.S. relates to declaratory remedies that are unrelated to the company's operations," Ashot stated in response.
Financial Impact and Market Response
Ashot's stock has lost about half its value over the past 12 months, dropping to a market capitalization of roughly 1.7 billion shekels. Despite the decline, it has yielded a return of about 970% over the past three years. The controlling shareholder and chairman is Zvi Levi.
In its recent financial reports, Ashot anticipated that a U.S. manufacturing license would be obtained in the second quarter of 2026, a forecast that has not materialized. Nonetheless, the company maintains that its global expansion strategy remains firmly on track.
